DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function

Completed · Phase 4

Conditions studied: Ventricular Ejection Fraction

In brief

The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).

Key facts

Study ID

NCT00401687

Run by

Lantheus Medical Imaging

People needed

131

Starts

2006-07-01

Expected to finish

2008-04-01

Last updated by the study team

2011-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult subjects 18 years of age or older
• Have a documented EF value ranging from 25% to 40%
• Have been scheduled to undergo or have undergone a cardiac MRI study

You may not qualify if…

• Severe valvular dysfunction
• Inability to remain supine for 30 minutes

Where it is running

• University of Arizona — Tucson, Arizona, United States
• University of Chicago Medical Center — Chicago, Illinois, United States
• Washington Hospital Center — Washington DC, Maryland, United States
• Saint Lukes Mid America Heart Institute — Kansas City, Missouri, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Cleveland Clinic Foundation — Cleveland, Ohio, United States
• Oregon Health & Science University — Portland, Oregon, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• University of Texas Medical Branch — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.